2Cantin M, Potential for antioxidant therapy of cystic fibrosis[J]. Curr Opin Pulm Med,2004, 10(6) :531
3Moss RB. Administration of aerosolized antibiotics in cystic fibrogis patients[J]. Chest ,2001, 120(3) : 107S.
4Sermet-Gaudelus I, Le Cocguic Y, Ferroni A,et al .Nebulized antibiotics in cystic fibrosis[J]. Paediatr Drugs,2003, 5(1):40.
5Beringer P. The clinical use of colistin in patients with cystic fibrosis[J].Curr Opin Pulm Med, 2001, 7(6):434.
6Le Brun PP,De Graaf AI,Vinks AA. High- performance liquid chromatographic method for the determination of colistin in serum[J]. Ther Drug Monit ,200022 (5) : 589.
7Alothman GA, Ho B, Alsaadi MM, et al .Bronchial constriction and inhaled colistin in cystic fibrosis[J]. Chest, 2005,127(2): 522.
9Cheer SM,Waugh J, Noble S. Inhaled tobramycin (TOBI(R)): a review of its use in the management of pseudomonas aeruginosa infections in patients with cystic fibrosis[J] . Drugs, 2003,63 (22) : 2 501.
2Mark Rabin,Michael Watson,Vincent Kidd,Savio L. C. Woo,W. Roy Breg,Frank H. Ruddle. Regional location of α1-antichymotrypsin and α1-antitrypsin genes on human chromosome 14[J] 1986,Somatic Cell and Molecular Genetics(2):209~214